ZA881053B - Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration - Google Patents

Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration

Info

Publication number
ZA881053B
ZA881053B ZA881053A ZA881053A ZA881053B ZA 881053 B ZA881053 B ZA 881053B ZA 881053 A ZA881053 A ZA 881053A ZA 881053 A ZA881053 A ZA 881053A ZA 881053 B ZA881053 B ZA 881053B
Authority
ZA
South Africa
Prior art keywords
compounds
prostaglandin
derivatives
pharmaceutical compositions
active agents
Prior art date
Application number
ZA881053A
Inventor
C. Froelich Juergen
Bippi Herbert
Original Assignee
C. Froelich Juergen
Bippi Herbert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C. Froelich Juergen, Bippi Herbert filed Critical C. Froelich Juergen
Publication of ZA881053B publication Critical patent/ZA881053B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Prostaglandin E1 derivatives as pharmacological active compounds and medicaments containing these compounds are described, in particular for transcutaneous application.
ZA881053A 1987-02-16 1988-02-16 Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration ZA881053B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873704825 DE3704825A1 (en) 1987-02-16 1987-02-16 PROSTAGLANDIN E1 DERIVATIVES AS PHARMACEUTICAL ACTIVE SUBSTANCES AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS, IN PARTICULAR FOR TRANSCUTANEAL USE

Publications (1)

Publication Number Publication Date
ZA881053B true ZA881053B (en) 1988-08-12

Family

ID=6321070

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881053A ZA881053B (en) 1987-02-16 1988-02-16 Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration

Country Status (11)

Country Link
EP (1) EP0292643B1 (en)
JP (1) JPS63246331A (en)
AT (1) ATE80616T1 (en)
AU (2) AU623336B2 (en)
CA (1) CA1327359C (en)
DE (2) DE3704825A1 (en)
DK (1) DK173552B1 (en)
ES (1) ES2043696T3 (en)
GR (1) GR3005743T3 (en)
HU (1) HU199687B (en)
ZA (1) ZA881053B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2939569A (en) * 1957-10-16 1960-06-07 Gay W Roach Cotton weighing machine
AU674054B2 (en) * 1993-02-03 1996-12-05 Teijin Limited Dermatologic preparation composition containing isocarbacyclin as active ingredient
CA2133334A1 (en) * 1993-02-03 1994-08-04 Atsuo Hazato External skin treatment agent composition containing prostacyclins as active ingredient
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
FR2812192B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF PROSTAGLANDIN EP-3 RECEPTOR ANTAGONISTS AS A COSMETIC AGENT FOR MITIGATING, REDUCING OR STOPPING HAIR AND HAIR LOSS
FR2812191B1 (en) * 2000-07-28 2003-10-17 Oreal USE OF PROSTAGLANDIN E2 RECEPTOR AGONISTS (EP-3) TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
FR2812190B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF NON-PROSTANOIC AGONISTS OF EP-2 AND / OR EP-4 PROSTAGLANDIN RECEPTORS AS A COSMETIC AGENT FOR MITIGATING, DECREASING OR STOPPING HAIR AND HAIR LOSS
FR2812193B1 (en) * 2000-07-28 2003-10-24 Oreal USE OF AN ANTAGONIST OF PROSTAGLANDIN EP-2 AND / OR EP-4 RECEPTORS TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
CN1777429A (en) 2003-04-02 2006-05-24 尼克美制药控股有限公司 Prostaglandin compositions and applications for the treatment of vasospasm
IT1402047B1 (en) * 2010-10-19 2013-08-28 Cross Pharma Sa USE OF MEXIPROSTIL IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES
RU2633236C2 (en) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Methods and compositions for raynaud disease treatment
US10383839B2 (en) 2011-06-30 2019-08-20 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
ITRM20120036A1 (en) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr TRANSDERMAL APPLICATION OF PROSTAGLANDINE E1 FOR THE TREATMENT OF OCULAR ISCHEMIA.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735005A (en) * 1970-08-19 1973-05-22 Alza Corp Method for preparing a viable platelet concentrate
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
JPS6022710B2 (en) * 1977-09-16 1985-06-03 小野薬品工業株式会社 Prostaglandin-like compounds
JPS59216820A (en) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd Fat emulsion of prostaglandin
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method

Also Published As

Publication number Publication date
DE3874610D1 (en) 1992-10-22
CA1327359C (en) 1994-03-01
JPS63246331A (en) 1988-10-13
AU649130B2 (en) 1994-05-12
AU623336B2 (en) 1992-05-14
EP0292643A1 (en) 1988-11-30
GR3005743T3 (en) 1993-06-07
AU1518492A (en) 1992-06-25
ATE80616T1 (en) 1992-10-15
DE3704825A1 (en) 1988-08-25
HUT46224A (en) 1988-10-28
DK173552B1 (en) 2001-02-26
HU199687B (en) 1990-03-28
ES2043696T3 (en) 1994-01-01
EP0292643B1 (en) 1992-09-16
AU1176688A (en) 1988-08-18
DK77588A (en) 1988-08-17
DK77588D0 (en) 1988-02-15

Similar Documents

Publication Publication Date Title
FI872864A0 (en) Process for the preparation of pharmaceutically active benzimidazole derivatives
IL89748A (en) Pharmaceutical compositions for systemic transdermal administration, containing deprenyl
IE894048L (en) New therapeutically active compound and a process for its¹preparation
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
TW234691B (en)
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
EP0620004A4 (en) Medicinal composition.
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
UA42733C2 (en) Bis-naphthalimide derivatives and pharmaceutically acceptable acid addition salts thereof, pharmaceutical composition containing them showing cytotoxic activity
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
AU2617288A (en) Pharmaceutical formulations for transdermal administration
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
SE7708622L (en) 2-BENZYL-PERHYDROAZEPINES, PREPARATIONS AND MEDICINAL PRODUCTS, CONTAINING THEM
MX9305578A (en) ADSORBATE BASED ON A MIXTURE OF AUXILIARY SUBSTANCES AND A SOLID ACTIVE PRINCIPLE FOR THE PRODUCTION OF DRUG PREPARATIONS.
DE3372772D1 (en) Quinazolinone derivatives, process for their preparation and their use in medicaments
GB1465771A (en) Pharmaceutical composition and use thereofd
JO1531B1 (en) Novel pharmacological compounds
JO1519B1 (en) Novel compounds (Novel deravatives of Benzimidazoles active as anti-ulcer agents).
FR2567755B1 (en) NEW ANTI-TUMOR DRUG CONTAINING TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT
IL89251A (en) Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents
IE871714L (en) Pharmaceutical compositions for topical administration